Literature DB >> 28374141

IGF-II-mediated downregulation of peroxisome proliferator-activated receptor-γ coactivator-1α in myoblast cells involves PI3K/Akt/FoxO1 signaling pathway.

Xiaoyu Mu1,2, Weihong Qi3, Yunzhang Liu1, Jianfeng Zhou1, Yun Li1, Xiaozhi Rong1, Ling Lu4.   

Abstract

Insulin-like growth factor II (IGF-II) can stimulate myogenesis and is critically involved in skeletal muscle differentiation. The presence of negative regulators of this process, however, is not well explored. Here, we showed that in myoblast cells, IGF-II negatively regulated peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) mRNA expression, while constitutive expression of PGC-1α induced myoblast differentiation. These results suggest that the negative regulation of PGC-1α by IGF-II may act as a negative feedback mechanism in IGF-II-induced myogenic differentiation. Reporter assays demonstrated that IGF-II suppresses the basal PGC-1α promoter activity. Blocking the IGF-II signaling pathway increased the endogenous PGC-1α levels. In addition, pharmacological inhibition of PI3 kinase activity prevented the downregulation of PGC-1α but the activation of mTOR was not required for this process. Importantly, further analysis showed that forkhead transcription factor FoxO1 contributes to mediating the effects of IGF-II on PGC-1 promoter activity. These findings indicate that IGF-II reduces PGC-1α expression in skeletal muscle cells through a mechanism involving PI3K-Akt-FoxO1 but not p38 MAPK or Erk1/2 MAPK pathways.

Entities:  

Keywords:  FoxO1; IGF-II; Myogenesis; PGC-1α

Mesh:

Substances:

Year:  2017        PMID: 28374141     DOI: 10.1007/s11010-017-3010-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  23 in total

Review 1.  Skeletal muscle formation in vertebrates.

Authors:  M Buckingham
Journal:  Curr Opin Genet Dev       Date:  2001-08       Impact factor: 5.578

Review 2.  Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation.

Authors:  Cunming Duan; Hongxia Ren; Shan Gao
Journal:  Gen Comp Endocrinol       Date:  2010-04-18       Impact factor: 2.822

Review 3.  Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs) pathways.

Authors:  Nadège Zanou; Philippe Gailly
Journal:  Cell Mol Life Sci       Date:  2013-04-04       Impact factor: 9.261

4.  Differential regulation of IGF-I and IGF-II gene expression in skeletal muscle cells.

Authors:  Shuang Jiao; Hongxia Ren; Yun Li; Jianfeng Zhou; Cunming Duan; Ling Lu
Journal:  Mol Cell Biochem       Date:  2012-10-10       Impact factor: 3.396

5.  Transcriptional effects of chronic Akt activation in the heart.

Authors:  Stuart A Cook; Takashi Matsui; Ling Li; Anthony Rosenzweig
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

6.  Total skeletal muscle PGC-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity.

Authors:  Christoph Zechner; Ling Lai; Juliet F Zechner; Tuoyu Geng; Zhen Yan; John W Rumsey; Deanna Collia; Zhouji Chen; David F Wozniak; Teresa C Leone; Daniel P Kelly
Journal:  Cell Metab       Date:  2010-12-01       Impact factor: 27.287

7.  FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts.

Authors:  Philippe R J Bois; Gerard C Grosveld
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

8.  HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha.

Authors:  Zoltan Arany; Shi-Yin Foo; Yanhong Ma; Jorge L Ruas; Archana Bommi-Reddy; Geoffrey Girnun; Marcus Cooper; Dina Laznik; Jessica Chinsomboon; Shamina M Rangwala; Kwan Hyuck Baek; Anthony Rosenzweig; Bruce M Spiegelman
Journal:  Nature       Date:  2008-02-21       Impact factor: 49.962

9.  AMPK inhibits myoblast differentiation through a PGC-1alpha-dependent mechanism.

Authors:  David L Williamson; David C Butler; Stephen E Alway
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-02       Impact factor: 4.310

10.  IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients.

Authors:  Ebru Erbay; In-Hyun Park; Paul D Nuzzi; Christopher J Schoenherr; Jie Chen
Journal:  J Cell Biol       Date:  2003-12-08       Impact factor: 10.539

View more
  3 in total

1.  FOXO1 inhibition prevents renal ischemia-reperfusion injury via cAMP-response element binding protein/PPAR-γ coactivator-1α-mediated mitochondrial biogenesis.

Authors:  Di Wang; Yanqing Wang; Xiantong Zou; Yundi Shi; Qian Liu; Tianru Huyan; Jing Su; Qi Wang; Fengxue Zhang; Xuejun Li; Lu Tie
Journal:  Br J Pharmacol       Date:  2019-12-23       Impact factor: 8.739

2.  Altered Brain Expression of Insulin and Insulin-Like Growth Factors in Frontotemporal Lobar Degeneration: Another Degenerative Disease Linked to Dysregulation of Insulin Metabolic Pathways.

Authors:  Connie J Liou; Ming Tong; Jean P Vonsattel; Suzanne M de la Monte
Journal:  ASN Neuro       Date:  2019 Jan-Dec       Impact factor: 4.146

3.  Sirt6 opposes glycochenodeoxycholate-induced apoptosis of biliary epithelial cells through the AMPK/PGC-1α pathway.

Authors:  Jiye Li; Dongsheng Yu; Sanyang Chen; Yifan Liu; Jihua Shi; Jiakai Zhang; Peihao Wen; Zhihui Wang; Jie Li; Wenzhi Guo; Shuijun Zhang
Journal:  Cell Biosci       Date:  2020-03-20       Impact factor: 7.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.